Mixed Results for Novel Drug for Osteoarthritis Mixed Results for Novel Drug for Osteoarthritis

MIV-711, a potent, selective cathepsin K inhibitor, was no better than placebo in relieving pain related to knee osteoarthritis in a randomized, placebo-controlled, phase 2a study. However, the drug led to a significant reduction in bone and cartilage progression.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Source Type: news